Prospective Stratification of Infectious Risks in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

298

Participants

Timeline

Start Date

April 10, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions
Multiple Sclerosis
Interventions
OTHER

MS-adapted AWIS questionnaire (MS-AWIS)

The predefined questionnaire-based infection score of the Airway Infection Susceptibility (AWIS) study is predictive for the occurrence of respiratory tract infections (RTI). In addition several MS-specific items (e.g. bladder dysfunction and urinary tract infections) are included into the AWIS questionnaire (MS-AWIS).

OTHER

infection diary (MS-AWIS diary)

MS patients prospectively fill out monthly infection diaries for 24 months. Infection diaries will either be sent back (with pre-franked envelopes) or handed back to the InRIMS-study team during regular clinical visits (usually every 6 or 12 months).

Trial Locations (1)

4031

University Hospital Basel, Department of Neurology, Basel

All Listed Sponsors
collaborator

Swiss Multiple Sclerosis Society

UNKNOWN

collaborator

Bangerter-Rhyner Stiftung

UNKNOWN

collaborator

Center for Chronic Immunodeficiency (CCI) in Freiburg, Germany

UNKNOWN

lead

University Hospital, Basel, Switzerland

OTHER

NCT04036097 - Prospective Stratification of Infectious Risks in Multiple Sclerosis | Biotech Hunter | Biotech Hunter